找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Diabetic Retinopathy; Current Pharmacologi Michael W. Stewart Book 2017 Mayo Foundation for Medical Education and Research 2017 Alpha agoni

[复制链接]
查看: 9534|回复: 43
发表于 2025-3-21 17:51:21 | 显示全部楼层 |阅读模式
书目名称Diabetic Retinopathy
副标题Current Pharmacologi
编辑Michael W. Stewart
视频video
概述A comprehensive introduction provides the reader an overview of the global diabetes epidemic and the relationship between diabetic retinopathy and systemic factors.A detailed discussion of the biochem
图书封面Titlebook: Diabetic Retinopathy; Current Pharmacologi Michael W. Stewart Book 2017 Mayo Foundation for Medical Education and Research 2017 Alpha agoni
描述.A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. ..Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option..Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed..
出版日期Book 2017
关键词Alpha agonist; Anabolic steroid; Angiogenesis; Angiopoietin; Anti-VEGF; Corticosteroid; Dexamethasone; Fluo
版次1
doihttps://doi.org/10.1007/978-981-10-3509-8
isbn_softcover978-981-10-9890-1
isbn_ebook978-981-10-3509-8
copyrightMayo Foundation for Medical Education and Research 2017
The information of publication is updating

书目名称Diabetic Retinopathy影响因子(影响力)




书目名称Diabetic Retinopathy影响因子(影响力)学科排名




书目名称Diabetic Retinopathy网络公开度




书目名称Diabetic Retinopathy网络公开度学科排名




书目名称Diabetic Retinopathy被引频次




书目名称Diabetic Retinopathy被引频次学科排名




书目名称Diabetic Retinopathy年度引用




书目名称Diabetic Retinopathy年度引用学科排名




书目名称Diabetic Retinopathy读者反馈




书目名称Diabetic Retinopathy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:19:21 | 显示全部楼层
发表于 2025-3-22 02:52:21 | 显示全部楼层
发表于 2025-3-22 04:34:04 | 显示全部楼层
发表于 2025-3-22 11:22:27 | 显示全部楼层
Héctor Wittwer,Daniel Schäfer,Andreas Frewerathy has generally been considered a vasculopathy that results from breakdown of the blood-retinal barrier and closure of retinal capillaries. Recent evidence, however, suggests that DR begins as a neuro-retinopathy with vascular changes occurring later during the disease.
发表于 2025-3-22 15:23:18 | 显示全部楼层
https://doi.org/10.1007/978-981-10-3509-8Alpha agonist; Anabolic steroid; Angiogenesis; Angiopoietin; Anti-VEGF; Corticosteroid; Dexamethasone; Fluo
发表于 2025-3-22 18:09:33 | 显示全部楼层
发表于 2025-3-22 23:04:37 | 显示全部楼层
The Diabetic Retina: Anatomy and Pathophysiology,athy has generally been considered a vasculopathy that results from breakdown of the blood-retinal barrier and closure of retinal capillaries. Recent evidence, however, suggests that DR begins as a neuro-retinopathy with vascular changes occurring later during the disease.
发表于 2025-3-23 02:23:07 | 显示全部楼层
发表于 2025-3-23 06:08:07 | 显示全部楼层
http://image.papertrans.cn/d/image/270486.jpg
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 12:29
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表